NewAmsterdam Pharma Company NV (NAMS) has a current stock price of $23.62. During the previous trading session, the stock witnessed a notable rise, reaching a high of $52.11 after opening at $23.62. The stock’s low for the day was $26.97, and it eventually closed at $21.73.
In terms of market performance, NewAmsterdam Pharma Company NV had a somewhat inconsistent run in.
52-week price history of NAMS Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. NewAmsterdam Pharma Company NV’s current trading price is -13.45% away from its 52-week high, while its distance from the 52-week low is 67.99%. The stock’s price range for this period has remained between $14.06 and $27.29. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.89 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.85 million over the last three months.
Financial Performance and Market Capitalization
NewAmsterdam Pharma Company NV (NAMS) has experienced a quarterly rise of 24.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.65B and boasts a workforce of 68 employees.
Analysts’ Ratings For NewAmsterdam Pharma Company NV
As of right now, 8 analysts are rating NewAmsterdam Pharma Company NV as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.73, with a change in price of +0.04. Similarly, NewAmsterdam Pharma Company NV recorded 894,150 in trading volume during the last 100 days, posting a change of +0.17%.
NAMS Stock Stochastic Average
As of today, the raw stochastic average of NewAmsterdam Pharma Company NV over the past 50 days is 85.07%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 72.04%. Additionally, the Stochastic %K and %D values for the company were 49.35% and 43.49%, respectively, over the past 20 days.
NAMS Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 38.78% this year. Over the last six months, there has been a weaker performance of 11.84%. The price of NAMS fallen by 17.98% during the last 30 days period. For the last 5-days stocks have improved 5.31%.
